Seems a meeting has been scheduled for another similar drug and since the committee will be together - at least that is what the Company is telling people. Claim FDA is well into label discussions.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.